Cargando…
5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency
Clks have been shown by recent studies to be promising targets for cancer therapy, as they are considered key regulators in the process of pre-mRNA splicing, which in turn affects every aspect of tumor biology. In particular, Clk1 and -4 are overexpressed in several human tumors. Most of the potent...
Autores principales: | ElHady, Ahmed K., El-Gamil, Dalia S., Chen, Po-Jen, Hwang, Tsong-Long, Abadi, Ashraf H., Abdel-Halim, Mohammad, Engel, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918793/ https://www.ncbi.nlm.nih.gov/pubmed/33668683 http://dx.doi.org/10.3390/molecules26041001 |
Ejemplares similares
-
Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives
por: ElHady, Ahmed K., et al.
Publicado: (2023) -
SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4
por: Tiek, Deanna, et al.
Publicado: (2023) -
Development of (4-Phenylamino)quinazoline Alkylthiourea Derivatives as Novel NF-κB Inhibitors
por: Darwish, Sarah S., et al.
Publicado: (2022) -
Controlling clots with Clk1
por: Williams, Ruth
Publicado: (2006) -
CLK1/CLK2-driven signalling at the Leishmania kinetochore is captured by spatially referenced proximity phosphoproteomics
por: Geoghegan, Vincent, et al.
Publicado: (2022)